389892047	389892047	CD	B-NP	O
|	|	NN	I-NP	O
RLH	RLH	NN	I-NP	O
|	|	NN	I-NP	O
81181123	81181123	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
657232	657232	CD	B-NP	O
|	|	CC	I-NP	O
11/28/2001	11/28/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GANGRENOUS	GANGRENOUS	NNP	I-NP	I-protein
RIGHT	RIGHT	NNP	I-NP	I-protein
FIRST	FIRST	NNP	I-NP	I-protein
TOE	TOE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2001	10/20/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/28/2001	5/28/2001	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
RIGHT	RIGHT	NN	I-NP	O
TIBIAL	TIBIAL	NN	I-NP	O
ARTERIAL	ARTERIAL	NN	I-NP	O
BYPASS	BYPASS	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57	57	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
right	right	JJ	I-NP	O
first	first	JJ	I-NP	O
toe	toe	NN	I-NP	O
wound	wound	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
erythema	erythema	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
toe	toe	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
rest	rest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
non	non	JJ	B-NP	O
insulin	insulin	NN	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
in	in	IN	B-PP	O
'96	'96	CD	B-NP	O
,	,	,	O	O
C-section	C-section	NN	B-NP	O
and	and	CC	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
cataracts	cataract	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Glucophage	Glucophage	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
B	B	NN	I-NP	O
multivitamin	multivitamin	NN	I-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d.	d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SURGICAL	SURGICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	NN	I-NP	O
,	,	,	O	O
mildly	mildly	RB	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

RIGHT	RIGHT	NN	B-NP	O
LOWER	LOWER	NN	I-NP	O
EXTREMITY	EXTREMITY	NN	I-NP	O
:	:	:	O	O
Had	Have	VBD	B-VP	O
a	a	DT	B-NP	O
non	non	JJ	I-NP	O
healing	healing	NN	I-NP	O
wound	wound	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
surrounding	surround	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
palpable	palpable	JJ	B-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
Dopplerable	Dopplerable	JJ	B-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
faintly	faintly	RB	I-NP	O
dopplerable	dopplerable	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
dopplerable	dopplerable	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Was	Wa	NNS	B-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
AVI	AVI	NN	B-NP	O
of	of	IN	B-PP	O
0.60	0.60	CD	B-NP	O
and	and	CC	I-NP	O
0.59	0.59	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PTT	PTT	NN	B-NP	O
respectively	respectively	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
with	with	IN	B-PP	O
mildly	mildly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
PVRs	PVR	NNS	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Laboratory	Laboratory	NN	B-NP	O
exams	exam	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
triple	triple	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
dressing	dress	VBG	B-VP	O
changes	change	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
non	non	JJ	I-NP	O
healing	healing	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
and	and	CC	B-PP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
11/11/2001	11/11/2001	CD	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Viteo	Viteo	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
and	and	CC	O	O
first	first	JJ	B-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regular	regular	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PCA	PCA	NN	I-NP	B-protein
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
two	two	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
regular	regular	JJ	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
pain	pain	NN	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
consultation	consultation	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
made	make	VBD	B-VP	O
some	some	DT	B-NP	O
adjustments	adjustment	NNS	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
three	three	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
leg	leg	NN	I-NP	O
wounds	wound	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
erythema	erythema	NN	I-NP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Ancef	Ancef	NN	B-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
erythema	erythema	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
and	and	CC	O	O
home	home	NN	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
home	home	NN	I-NP	O
visiting	visiting	NN	I-NP	O
nurses	nurse	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
is	be	VBZ	B-VP	O
ADA	ADA	NNP	B-NP	O
2100	2100	CD	I-NP	O
;	;	:	O	O
her	her	PRP$	B-NP	O
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	RB	B-ADJP	O
tolerated	tolerate	VBN	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Goldsby	Goldsby	NNP	I-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
3/15	3/15	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
to	to	TO	I-VP	O
schedule	schedule	VB	I-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
baid	baid	NN	I-NP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
one	one	CD	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	B-protein
p.o.	p.o.	FW	I-NP	I-protein
q	q	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
B	B	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Glucophage	Glucophage	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
and	and	CC	O	O
Keflex	Keflex	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
x	x	SYM	O	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
GERARD	GERARD	NNP	B-NP	O
OVERDICK	OVERDICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LN505	LN505	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EDWARD	EDWARD	NNP	B-NP	O
O.	O.	NNP	I-NP	O
OWERS	OWERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WY60	WY60	NNP	I-NP	O
BP017/0073	BP017/0073	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
99151	99151	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

Z4OBEE3S06	Z4OBEE3S06	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
2/28/01	2/28/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/28/01	2/28/01	CD	B-NP	O

